Dextromethorphan’s Hidden Trip
Bottom line: Dextromethorphan may suggest psychedelic effects and was associated with potential therapeutic applications in psychiatric disorders, though evidence remains limited and requires further research.
In the back alleys of online forums, people talk about dextromethorphan (DXM), a drug found in many over-the-counter cough syrups. Some say it can make users feel things they describe as hallucinations or mystical experiences. These claims have caught the attention of researchers, who are now examining whether DXM might have a place in treating mental health conditions that don’t respond to standard treatments. A recent review of existing studies gives a glimpse into how DXM might work, what doses could be involved, and what risks might come with it.
Uncovering the Psychedelic Effects
A systematic review looked at eight studies involving 104 people. It found that at 100 mg, DXM can cause mild psychedelic effects, and at 300 or 400 mg, these experiences grow stronger. But the higher the dose, the more likely people are to report nausea, vomiting, problems with movement, and slower thinking. These findings show that DXM’s psychedelic effects depend on the dose, but the evidence is still limited. The study points to a need for more research—particularly larger, well-designed trials.
The Therapeutic Potential
The idea that DXM might help people with treatment-resistant mental health disorders is interesting. Its ability to cause psychedelic experiences could mean it might be used for conditions like depression, anxiety, or PTSD. But the study also says the details about how much to use, how safe it is, and how it affects the body are still unclear. The evidence is too weak to make strong claims about its potential as a treatment.
Comparison to Other Psychedelics
DXM’s effects have been compared to those of other drugs, like LSD and ketamine. While the exact reasons it works are still unknown, it seems to cause similar kinds of hallucinations and mystical feelings. But its chemical makeup and the way it might be used in treatment are different. This makes it worth studying more, especially in the context of mental health.
The Challenge of Dose-Response Relationships
Understanding how DXM works at different doses is one of the biggest problems researchers face. The review shows that psychedelic effects start at 100 mg, and get stronger at 300 or 400 mg. But at 200 mg or higher, the risks of side effects like nausea and vomiting go up. This suggests that the window between a useful dose and a harmful one is narrow. That makes careful control over how much is used important in any future treatment plans.
Frequently Asked Questions
-
What is dextromethorphan (DXM), and how is it used?
DXM is a common over-the-counter cough suppressant that has been found to exhibit psychedelic effects at supratherapeutic levels. -
What are the potential therapeutic applications of DXM?
DXM may have potential therapeutic applications in treating treatment-resistant psychiatric disorders, such as depression, anxiety, and PTSD. -
What are the risks associated with using DXM for its psychedelic effects?
The use of DXM for its psychedelic effects is associated with risks such as nausea, vomiting, motor impairment, and cognitive slowing, particularly at higher doses. -
How does DXM compare to other psychedelics?
DXM’s psychedelic effects have been compared to those of classic and dissociative psychedelics, but its unique pharmacological profile and potential therapeutic applications set it apart from other substances. -
What further research is needed to understand DXM’s therapeutic potential?
Further research is needed to fully understand DXM’s dose-response relationships, therapeutic dosing parameters, and safety profile, as well as its potential efficacy in treating psychiatric disorders.
Sources
- ¶Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review
- ¶Future Therapeutic Strategies for Alzheimer’s Disease: Focus on Behavioral and Psychological Symptoms
- ¶Future Therapeutic Strategies for Alzheimer’s Disease: Focus on Behavioral and Psychological Symptoms
Educational Disclaimer
This article is for informational and educational purposes only. It is not medical advice, mental health advice, diagnosis, treatment guidance, or a recommendation to use any substance, supplement, therapy, or protocol.
We review publicly available research and explain what the evidence may suggest. Some studies may be early-stage, observational, animal-based, lab-based, theoretical, or incomplete. Always consult a qualified professional before making health-related decisions.
If you or someone you know is struggling, you are not alone. In the US, call or text 988 (Suicide & Crisis Lifeline). Elsewhere, contact your local emergency or crisis service.
Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.
